-
Most Recent
Search Results
240 results for abv
AbbVie Earnings: ABBV Stock Jumps More Than 6% on Q4 Beats
AbbVie (ABBV) earnings for the biopharmaceutical company’s fourth quarter of 2019 have ABBV stock heading higher on Friday.
Trade of the Day: ABBV Stock on the Verge of a Major Breakout
AbbVie Inc is challenging the recent double-top above $65.
Trump’s Iran Update Spikes Volatility. Now What?
Stocks gyrate after Trump extends the Iran timeline… what yesterday’s jobs data tells us… AI agents are coming for jobs… how to invest ahead of…
ABBV Stock: The FDA Blow That Just Sent AbbVie Tumbling on Wednesday
Here’s the big FDA-related news today that’s sparking a sharp selloff of pharmaceutical giant AbbVie and ABBV stock.
5 Top Stock Trades for Wednesday: ATVI, SHOP, CHGG, ABT, ABBV
Activision Blizzard, Shopify, Chegg, Abbott Labs and AbbVie were our top stock trades for Wednesday. That said, here’s a look at the charts.
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500.
Best-in-Class Quant Score Makes AbbVie (ABBV) a Strong Buy
AbbVie Inc (NYSE:ABBV) ranks in the top 10% of its industry group, Biotechnology, and in the top decile of sector group, Health Care, with a…
What Are AbbVie Shareholders Getting for Their $21 Billion? (ABBV, PCYC, JNJ)
AbbVie (ABBV) beat Johnson & Johnson (JNJ) to the punch with the deal to acquire Pharmacyclics (PCYC), but was it worth the hefty price tag?
Why AbbVie Inc (ABBV) Stock Is Still a Long-Term Winner
The market has been hot and cold on biotechs, but AbbVie stock is a great long-term winner. Here’s what you need to know about ABBV.
ABBV Stock: Could AbbVie Inc’s Gamble on Stemcentrx Pay Off?
Stemcentrx’s acquisition does little to alleviate the risk of the potential decrease in sales once Humira loses patent protection.
AbbVie Stock News: Why ABBV Is the Top Trending Ticker Today
AbbVie stock is the top trending ticker on Yahoo Finance Thursday earnings news has ABBV investors pumped up this morning.
Stop Guessing the Market. Use AI Trading Signals Instead
Forget forecasts. AI trading signals identify repeatable patterns that drive profits in any market environment.
AbbVie Earnings: 5 Things for ABBV Stock Investors to Know About Q1
AbbVie (ABBV) earnings for the biopharmaceutical company’s first quarter of 2020 have ABBV stock on the move Friday after beating estimates.
AbbVie Inc (ABBV) Stock Isn’t Done Charting New Highs Yet
Pharma is a fast moving sector and the doors close quickly. With AbbVie’s (ABBV) door open, sell ABBV stock puts now!
AbbVie Earnings: ABBV Stock Drops 2% Despite Q2 Beats
AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street.
High-Level Measures for Earnings Momentum Keep AbbVie (ABBV) a Strong Buy
Currently, AbbVie Inc (NYSE:ABBV) has a Strong Buy using Louis Navellier’s methodology for investing and his Portfolio Grader stock evaluator. ABBV has recently seen its…
AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV
AbbVie has significant challenges, but they’re also not unique ones. Sizing up the outlook leads to a slightly bullish stance on ABBV stock.
Humira Sales Help AbbVie Inc (ABBV) to a Q1 Earnings Beat
AbbVie Inc, a pharmaceuticals company, has released its earnings report for the first quarter of 2015 and it beat analysts’ estimates
AbbVie News: 5 Things for ABBV Investors to Know About Q3
AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company’s earnings report for the third quarter of 2020.
The Question Every Investor Gets Wrong
Keith is joining us today to explain how his team is using AI to uncover these kinds of “signals” across thousands of stocks. It’s the…
Quant Ratings Updated on 112 Stocks
Today, I want to briefly discuss the current situation between the U.S. and Iran. Then I’ll tell you about the bigger shift I think will…
What Anthropic’s Latest Model Signals for Investors
In today’s Smart Money, let’s examine the latest AI developments that are leading the push toward AGI. Then, I’ll share my three-part investment strategy you…
This Pharmaceutical Company is Oversold and Starting to Recover
This morning, I am recommending a bullish trade on AbbVie, Inc. (NYSE:ABBV), the biopharmaceutical company.
Nasdaq May Be In For a Tumble
The Nasdaq is looking very tired and barely able to hold above its 20-day moving average.
8 – 10 of 240 results
